Parexel International (ma) Corporation

Location

Massachusetts

Founded

1983-02-28

Website

https://www.parexel.com

Risk Signals

455 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Executive Leadership Changes (2) Acquisition Announcements (2) Corporate Governance Policies (1) Sustainable Product Design (1) Recruitment Activities (1) Research and Development (1) Business Growth Initiatives (1)

Recent Articles about Parexel International (ma) Corporation

Live alerts from global media, monitored by Business Radar

Riverside Partners' Portfolio Company, Syner-G BioPharma Group, Appoints Ron Kraus as CEO

2022-06-14 (prnewswire.com)

Riverside Partners' Portfolio Company, Syner-G BioPharma Group, Appoints Ron Kraus as CEO

/PRNewswire/ -- Riverside Partners, a Boston based private equity firm, announced today that its portfolio company, Syner-G BioPharma Group ("Syner-G" or the...

Read more

Never miss a headline about Parexel International (ma) Corporation

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages